Skip to content

Drug interactions

Nilotinib + Tecovirimat

Severity: Minor

Nilotinib and Tecovirimat: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tecovirimat is a weak CYP3A4 inducer and may modestly reduce nilotinib concentrations. This is usually short-term because tecovirimat courses are brief.

What this interaction means in plain words

Nilotinib and Tecovirimat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Nilotinib belongs to Oncology; Tecovirimat belongs to Miscellaneous.

Evidence level: Low

Why it happens

Weak CYP3A4 induction by tecovirimat increases nilotinib clearance.

What to do

No empiric dose change is generally needed for a short course. Monitor clinical response to nilotinib.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Nilotinib and Tecovirimat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Nilotinib with Tecovirimat?

MediHelp rates the interaction as minor. Nilotinib and Tecovirimat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Tecovirimat is a weak CYP3A4 inducer and may modestly reduce nilotinib concentrations. This is usually short-term because tecovirimat courses are brief.

How serious is the interaction between Nilotinib and Tecovirimat?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empiric dose change is generally needed for a short course. Monitor clinical response to nilotinib.

What other medicines interact with Nilotinib?

MediHelp also lists interactions of Nilotinib with, for example, Amiodarone, Arsenic trioxide, Disopyramide. The full list is on the Nilotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in